These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25168483)

  • 1. Injectable sumatriptan for cyclic vomiting syndrome in adults: a case series.
    Calhoun AH; Pruitt AP
    Headache; 2014 Oct; 54(9):1526-30. PubMed ID: 25168483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal sumatriptan for acute treatment of migraineurs with baseline nausea.
    Schulman EA
    Headache; 2012 Feb; 52(2):204-12. PubMed ID: 22229837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promethazine plus sumatriptan in the treatment of migraine: a randomized clinical trial.
    Asadollahi S; Heidari K; Vafaee R; Forouzanfar MM; Amini A; Shahrami A
    Headache; 2014 Jan; 54(1):94-108. PubMed ID: 24182419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological synergy: the next frontier on therapeutic advancement for migraine.
    Blumenfeld A; Gennings C; Cady R
    Headache; 2012 Apr; 52(4):636-47. PubMed ID: 22221151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of cyclic vomiting syndrome: a systematic review.
    Lee LY; Abbott L; Mahlangu B; Moodie SJ; Anderson S
    Eur J Gastroenterol Hepatol; 2012 Sep; 24(9):1001-6. PubMed ID: 22634989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OnabotulinumtoxinA Injections for the Treatment of Cyclic Vomiting Syndrome.
    Hayes WJ; Weisensee LA; Kappes JA; Dalton SM; Lemon MD
    Pharmacotherapy; 2015 May; 35(5):e51-5. PubMed ID: 25823714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
    Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
    Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic Vomiting Syndrome in 41 adults: the illness, the patients, and problems of management.
    Fleisher DR; Gornowicz B; Adams K; Burch R; Feldman EJ
    BMC Med; 2005 Dec; 3():20. PubMed ID: 16368014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic migraine: a 3-month comparator study of naproxen sodium vs SumaRT/Nap.
    Cady R; Nett R; Dexter K; Freitag F; Beach ME; Manley HR
    Headache; 2014 Jan; 54(1):80-93. PubMed ID: 24020994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sumatriptan (50 mg tablets vs. 25 mg suppositories) in the acute treatment of menstrually related migraine and oral contraceptive-induced menstrual migraine: a pilot study.
    Facchinetti F; Allais G; Nappi RE; Gabellari IC; Di Renzo GC; Genazzani AR; Bellafronte M; Roncolato M; Benedetto C
    Gynecol Endocrinol; 2010 Oct; 26(10):773-9. PubMed ID: 20528213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumatriptan iontophoretic transdermal system: history, study results, and use in clinical practice.
    Pierce M; O'Neill C; Felker E; Sebree T
    Headache; 2013 Sep; 53 Suppl 2():34-42. PubMed ID: 24024601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sumatriptan transdermal system can be correctly assembled and applied during migraine attacks.
    Meadows KP; Pierce M; O'Neill C; Foster S; Jennings C
    Headache; 2014 May; 54(5):850-60. PubMed ID: 24708392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic nausea and vomiting in childhood.
    Forbes D; Fairbrother S
    Aust Fam Physician; 2008; 37(1-2):33-6. PubMed ID: 18239750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sumatriptan iontophoretic transdermal system for the acute treatment of migraine.
    Vikelis M; Mitsikostas DD; Rapoport AM
    Pain Manag; 2014 Mar; 4(2):123-8. PubMed ID: 24641436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic vomiting syndrome and migraine in children.
    Lin YP; Ni YH; Weng WC; Lee WT
    J Formos Med Assoc; 2011 Jun; 110(6):382-7. PubMed ID: 21741006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twelve-month tolerability and efficacy study of NP101, the sumatriptan iontophoretic transdermal system.
    Smith TR; Goldstein J; Singer R; Pugach N; Silberstein S; Pierce MW
    Headache; 2012 Apr; 52(4):612-24. PubMed ID: 22352764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sumatriptan in the treatment of cyclic vomiting.
    Benson JM; Zorn SL; Book LS
    Ann Pharmacother; 1995 Oct; 29(10):997-9. PubMed ID: 8845562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic vomiting syndrome: what a gastroenterologist needs to know.
    Pareek N; Fleisher DR; Abell T
    Am J Gastroenterol; 2007 Dec; 102(12):2832-40. PubMed ID: 18042112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications for breath-powered powder sumatriptan intranasal treatment.
    Tepper SJ
    Headache; 2013 Sep; 53(8):1341-9. PubMed ID: 23809006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic vomiting syndrome: case report and short review of the literature.
    Van Driessche A; Sermijn E; Paemeleire K; Van Coster R; Vogelaers D
    Acta Clin Belg; 2012; 67(2):123-6. PubMed ID: 22712168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.